Novautek Autonomous Driving Limited, a Hong Kong-based innovation technology company specializing in artificial intelligence and autonomous driving technology, has been awarded the "Outstanding SME ESG and Business Performance Award 2024" by The Hang Seng University of Hong Kong. The award recognizes Novautek's outstanding performance in Environmental, Social and Governance (ESG) practices and its achievements in promoting sustainable development. Novautek's CEO, Mr. Wang Chunsheng, received the award, which aims to encourage small and medium enterprises to invest in ESG upgrades and transformation. Novautek is a subsidiary of Applied Development Holdings Limited and focuses on building a complete ecosystem across key areas like AI robotics, autonomous driving, and large AI models. The company has introduced five core applications of autonomous driving robots, including cleaning and sanitation, security patrol, transportation, delivery, and smart warehousing, which have been deployed in local housing estates to alleviate social challenges such as aging populations and labor shortages.
https://www.malaymail.com/news/money/mediaoutreach/2024/12/23/novautek-honored-with-the-outstanding-sme-esg-and-business-performance-award/352131Tevogen Bio will host an AI panel at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 13, 2025. The discussion, titled "AI in Biopharma: Next Frontier of Medical Innovation," will feature Dr. David Rhew from Microsoft and Mittul Mehta from Tevogen.AI, along with Dr. Sean Tunis from Rubix Health. They will explore the potential of AI to revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster innovation, and reduce costs. The panel will highlight how Tevogen's AI capabilities are being used to advance precision T cell therapies for various diseases.
https://www.manilatimes.net/2024/12/23/tmt-newswire/globenewswire/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-jp-morgan-healthcare-conference/2026860